213 related articles for article (PubMed ID: 8981568)
1. Botulinum toxin as a therapeutic agent.
Tsui JK
Pharmacol Ther; 1996; 72(1):13-24. PubMed ID: 8981568
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic uses of botulinum toxin.
Wheeler AH
Am Fam Physician; 1997 Feb; 55(2):541-5, 548. PubMed ID: 9054223
[TBL] [Abstract][Full Text] [Related]
3. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
Price J; Farish S; Taylor H; O'Day J
Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
[TBL] [Abstract][Full Text] [Related]
4. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin in movement disorders.
Papapetropoulos S; Singer C
Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin in clinical practice.
Hughes AJ
Drugs; 1994 Dec; 48(6):888-93. PubMed ID: 7533696
[TBL] [Abstract][Full Text] [Related]
7. Botulinum A toxin (Oculinum) in ophthalmology.
Osako M; Keltner JL
Surv Ophthalmol; 1991; 36(1):28-46. PubMed ID: 1925943
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin A: experience in the treatment of 115 patients].
Andrade LA; Borges V; Ferraz HB; Azevedo-Silva SM
Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404
[TBL] [Abstract][Full Text] [Related]
9. Movement, visceral and autonomic disorders: use of botulinum toxin.
Moore AP
Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin: structure and pharmacology.
Hambleton P
Eur Arch Otorhinolaryngol; 1994 Dec; ():S200-2. PubMed ID: 10774350
[No Abstract] [Full Text] [Related]
11. Current clinical applications of botulinum toxin.
Truong DD; Stenner A; Reichel G
Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419
[TBL] [Abstract][Full Text] [Related]
12. On muscle spindles, dystonia and botulinum toxin.
Rosales RL; Dressler D
Eur J Neurol; 2010 Jul; 17 Suppl 1():71-80. PubMed ID: 20590812
[TBL] [Abstract][Full Text] [Related]
13. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
Ainsworth JR; Kraft SP
Ophthalmology; 1995 Dec; 102(12):2036-40. PubMed ID: 9098314
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Kenney C; Jankovic J
J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin.
Consens Statement; 1990 Nov 12-14; 8(8):1-20. PubMed ID: 2098181
[TBL] [Abstract][Full Text] [Related]
16. The current use of botulinum toxin.
Mahant N; Clouston PD; Lorentz IT
J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
[TBL] [Abstract][Full Text] [Related]
17. [Botulinum toxin: clinical uses and anesthetic implications].
Vidal-Marcos A; Sanz-García M; Infante-Crespo B; Ruiz-Castro M; Rustarazo-Pérez MT; Palma-Gámiz MA
Rev Esp Anestesiol Reanim; 1996; 43(6):208-11. PubMed ID: 8756235
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin: potent poison, potent medicine.
Simpson LL
Hosp Pract (1995); 1999 Apr; 34(4):87-91; quiz 163. PubMed ID: 10212633
[TBL] [Abstract][Full Text] [Related]
19. Xeomin: an innovative new botulinum toxin type A.
Frevert J
Eur J Neurol; 2009 Dec; 16 Suppl 2():11-3. PubMed ID: 20002741
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
